Mostrando 6 resultados de: 6
Filtros aplicados
Subtipo de publicación
Article(6)
Publisher
Circulation(2)
JAMA Cardiology(1)
JAMA Neurology(1)
New England Journal of Medicine(1)
The Lancet Respiratory Medicine(1)
Área temáticas
Enfermedades(4)
Medicina y salud(4)
Fisiología humana(1)
Problemas sociales y servicios a grupos(1)
Área de conocimiento
Medicina interna(5)
Enfermedad cardiovascular(4)
Ensayo clínico(2)
Salud pública(1)
Colchicine and aspirin in community patients with COVID-19 (ACT): an open-label, factorial, randomised, controlled trial
ArticleAbstract: Background: The large number of patients worldwide infected with the SARS-CoV-2 virus has overwhelmePalabras claves:Autores:Ali Z., Anand S.S., Avezum A.J., Bangdiwala S.I., Belley-Cote E.P., Berwanger O., Bosch J.J., Choudhri S., Dans A.L., Eikelboom J.W., Farkouh M.E., Felix Camilo, Harper W.L., Hassany M., Heenan L., Jolly S.S., Kontsevaya A., Loeb M., Lopes R.D., Pais P., Palileo-Villanueva L.M., PATRICIO LOPEZ -JARAMILLO, Rangarajan S., Sharma S.K., Tarhuni W.M., Wasserman S., Whitlock R.P., Xavier D., Xu L., Yusuf S., Yusufali A.M.Fuentes:googlescopusApolipoprotein B, Residual Cardiovascular Risk After Acute Coronary Syndrome, and Effects of Alirocumab
ArticleAbstract: Background: Apolipoprotein B (apoB) provides an integrated measure of atherogenic risk. Whether apoBPalabras claves:acute coronary syndrome, apolipoproteins B, cholesterol, LDL, Heart Disease Risk Factors, PCSK9 inhibitorsAutores:Aylward P.E., Bhatt D.L., Bittner V.A., Danchin N., Diaz R., Dilic M., Drexel H., Edelberg J.M., Goodman S.G., Gotcheva N.N., Hagström E., Hanotin C., Harrington R.A., Jukema J.W., Lecorps G., Liberopoulos E., Lopes R.D., Mahaffey K.W., Manvelian G., Marx N., McGinniss J., Moryusef A., Ostadal P., PATRICIO LOPEZ -JARAMILLO, Pecin I., Pordy R., Poulsen S.H., Prieto J.C., Reiner Z., Roe M.T., Sasiela W.J., Scemama M., Schwartz G.G., Sinnaeve P.R., Steg P.G., Szarek M., Tamby J.F., Tricoci P., Viigimaa M., White H.D., Yong H., Zeiher A.M.Fuentes:scopusAlirocumab and cardiovascular outcomes after acute coronary syndrome
ArticleAbstract: BACKGROUND Patients who have had an acute coronary syndrome are at high risk for recurrent ischemicPalabras claves:Autores:Alexander J.H., Alexander K., Alings M., Armaganijan L., Aylward P.E., Bagai A., Bahit M.C., Bhatt D.L., Bittner V.A., Brennan J.M., Budaj A.J., Chaitman B., Chiang C.E., Chua T., Chumburidze V., Clifton S., Correa Flores R.M., Dalby A.J., Danchin N., De Silva H.A., Deloatch S., Devore A.D., DIaz R., Dickey S., Dilic M., Dombrowski K., Dorobantu M., Drexel H., Ducrocq G., Eapen Z., Edelberg J.M., Erglis A., Fras Z., Goodman S.G., Gotcheva N.N., Guneri S., Hagström E., Halvorsen S., Hanotin C., Harrington R.A., Jukema J.W., Karpov Y., Kedev S., Kelsey S.F., Kim H.S., Kim S.H., Kimura T., Kiss R.G., Laucevicius A., Lecorps G., Liberopoulos E., Lopes R.D., Mahaffey K.W., Marx N., Meloni C., Morais J., Moriarty P.M., Moryusef A., Müller C.E., Murin J., Nieminen M.S., Olsson A.G., Ostadal P., Parkhomenko A.N., PATRICIO LOPEZ -JARAMILLO, Pecin I., Pordy R., Poulsen S.H., Prieto J.C., Quintero K., Ramos López G.A., Ray K.K., Reiner Z., Ristic A.D., Roe M.T., Rosenson R., Rouleau J.L., Sasiela W.J., Schwartz G.G., Sijbrands E.J.G., Simoons M.L., Sinnaeve P.R., Sritara P., Steg P.G., Sy R.G., Szarek M., Tamby J.F., Tricoci P., Tse H.F., Tuñón J., Valdovinos P.C.M., Valgimigli M., Viigimaa M., Vogel R., White H.D., Xavier D., Yong H., Yusoff K., Zahger D., Zeiher A.M.Fuentes:scopusEffect of a Multifaceted Quality Improvement Intervention on the Prescription of Evidence-Based Treatment in Patients at High Cardiovascular Risk in Brazil: The BRIDGE Cardiovascular Prevention Cluster Randomized Clinical Trial
ArticleAbstract: Importance: Studies have found that patients at high cardiovascular risk often fail to receive evidePalabras claves:Autores:Almeida A.S., Amodeo C., Baldissera V., Baréa J.A.B., Barros E Silva P.G.D.M., Barroso S.L., Becke G.C.M., Bergo R.R., Berwanger O., Brandão Da Silva N., Campos V.B., Caron V., Conte D., Corrêa J.V.S., da Silva N.B., da Silva S.S., da Silva Serra K.C.C., da Silveira L., da Veiga V.d.F.N., Damiani L.P., Dantas J.M.M., de Assis R.M., de Barros E.F., de Figueiredo Neto J.A., de Moraes J.B.d.M.X., de Oliveira Silveira M.G., del Monaco M.I., do Brasil C.K.O.I., do Canto Filho M.J., do Carmo J.B., Domingues L.H., dos Santos E.V., dos Santos J.C., Duro L.N., Esper R.B., Esteves M.W., Feier A.P., Fernandes L.A.B., Filho J.A.S.B., Fonseca F.H., Fortes J.A.R., Gomes S.P.D.C., Gonçalves M.R., Gonzales B.P., Grezzana G.B., Guerra S.D., Guimarães H.P., Izar M.C., Jardim P.C.B.V., Kodama A., Kopittke L., Leães P.E., Lopes C.D., Lopes R.D., Lourenço S., Luiz R.O., Machline-Carrion M.J., Marcela G.d.O.A., Martin J.F.V., Martins G.L., Moraes M.J.D., Nakagawa R.H., Neto E.L., Neves M.F., Nobre F., Octavio Marques Pontes-Neto, Ormundo C., Orto F.T.C.D., Osugue R.K., Pauli C., Piegas L.S., Pinheiro S., Precoma D.B., Ramacciotti E., Ribeiro G.R., Rocha M.d.F., Sampaio B., Santo J.C.M.D.A., Santos J.Y., Santos P.D., SARAIVA J.O.S.E., Sehnem E., Silva A.L., Silva L.d.O., Silva L.P.W., Silva T.P., Silveira F.S., Sirena S.A., Soares R.M., Sousa A.L.L., Souza S.d.A.R., Stein A.T., Tobias J.S.P., Trama L.M., Vicente C.C., Wanderley F.F., Werle L., Woehl J., Ziebell J.V.Fuentes:scopusEffect of a Quality Improvement Intervention on Adherence to Therapies for Patients with Acute Ischemic Stroke and Transient Ischemic Attack: A Cluster Randomized Clinical Trial
ArticleAbstract: Importance: Translating evidence into clinical practice in the management of acute ischemic stroke (Palabras claves:Autores:Bahit M.C., Berwanger O., Bettger J.P., Bueno P.R.T., Cavalcanti A.B., Damiani L.P., De Andrade Jesuíno I., De Salles A., Gorgulho A., Guimarães H.P., Lopes R.D., Machline-Carrion M.J., Málaga G., Martins S.O., Normilio-Silva K., Octavio Marques Pontes-Neto, Pacheco Da Silva B.G., Peterson E.D., Rodrigues De Freitas G., Santos J.Y., Santucci E.V., Xian Y., Zétola V.H.F.Fuentes:scopusRisk Categorization Using New American College of Cardiology/American Heart Association Guidelines for Cholesterol Management and Its Relation to Alirocumab Treatment Following Acute Coronary Syndromes
ArticleAbstract: Background: The 2018 US cholesterol management guidelines recommend additional lipid-lowering therapPalabras claves:acute coronary syndrome, alirocumab, dyslipidemias, GUIDELINEAutores:Baccara-Dinet M.T., Bhatt D.L., Bittner V.A., DIaz R., Goodman S.G., Harrington R.A., Jukema J.W., Li Q.H., Lopes R.D., Louie M.J., Moriarty P.M., PATRICIO LOPEZ -JARAMILLO, Roe M.T., Schwartz G.G., Steg P.G., Szarek M., Vogel R., White H.D., Zeiher A.M.Fuentes:googlescopus